Korean biopharmaceutical companies aim to release generic versions of Amgen's Otezla (ingredient: apremilast), a psoriasis treatment.A total of seven Korean pharmaceutical companies, including Daewoong Pharmaceutical, Dong-A ST, Dongkoo Bio and Pharma, Huons, and Chong Kun Dang, succeeded in avoidin
Daewoong Pharmaceutical said on Wednesday it signed a joint R&D agreement with Neurorive to develop new drug candidates for depression treatment.NR-0601 is an oral antidepressant derived from Neurorive's drug screening platform that sends electrical signals to living brain tissues to check the respo
Takeda Pharmaceutical's orphan drug, Livtencity (ingredient: maribavir), received approval from the Ministry of Food Drug Safety (MFDS) on Tuesday to treat post-transplant cytomegalovirus.Cytomegalovirus (CMV) is a common virus that stays in the human body for life once the person becomes infected.
In 2022, the Korean healthcare industry seemed to be out of the Covid-19 shock. However, the industry had a rough year amid the economic downturn, jittery investor sentiment, and higher costs of imported raw materials. Nevertheless, the local healthcare industry showed a glimpse of future growth as
GI Cell said on Tuesday that it obtained the regulatory approval for human cell management under the "Act on the Safety and Support for Advanced Regenerative Medicine and Advanced Biological Products." The latest nod allows the company to manufacture cell therapies used for clinical trials, which co
Hanmi Pharmaceutical targets the gastritis treatment market with Esomezol DR SR Cap. 10 mg (esomeprazole magnesium trihydrate), or Esomezol DR 10 mg, released by the company early this month.Amid the intensifying competition over gastritis treatments among various medicines and components, industry
Boryung Corp. (former Boryung Pharmaceutical) is speeding up the new combination therapy by adding dyslipidemia treatment to the high blood-pressure drug.Industry analysts watch with interest whether the drugmaker can add new names to its flagship pipeline of the “Kanarb family.”In a public filing l
Celltrion Healthcare said on Monday that it supplied its anti-cancer antibody biosimilar Herzuma (ingredient: trastuzumab) for the treatment of breast and stomach cancer to Ukrainian patients via the Korea International Cooperation Agency (KOICA).The drug supply was led by KOICA, Korea’s development
Novartis Korea said on Monday that its advanced and metastatic breast cancer treatment Kisqali (ingredient: ribociclib) extended progression-free survival (PFS) by about one year compared to combination chemotherapy in first-line treatment of patients with aggressive premenopausal and HER2-advanced
A survey showed that the Korean pharmaceutical industry prioritizes waste disposal issues in the environmental category among ESG (environmental, social, governance) strategies. According to the survey conducted by the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPMBA) on 71 compa
Eight pharmaceutical ingredients subject to reassessment of insurance benefits – avocado-soybean unsaponifiable (Imotun Cap.) and adenine hydrochloride plus six others (Godex Cap.) -- have received “maintain” decisions from a related panel after a month-long delay of deliberation.Avocado-soybean uns
The U.S. patent for Humira (ingredient: adalimumab), a representative blockbuster drug of AbbVie and the world's top-selling drug, will expire next year.As most of Humira's sales come from the U.S., industry watchers expect that competition in the U.S. adalimumab market will intensify as numerous ph
Following Roche’s Tigagolumab, Gilead’s anti-TIGIT antibody candidate substance, Domvanalimab, has also shown consistent survival benefits when combined with anti-PD (programmed cell death)-(ligand) 1 antibody in phase 2 clinical trials.T-cell immunoreceptors with immunoglobulin and ITIM domains (TI
Peptron said on Wednesday that it failed to secure statistical significance of the primary endpoint for its Parkinson’s disease treatment candidate (PT320) in phase 2a clinical trials but will continue developing the drug. Parkinson's patients at five hospitals including Seoul National University Ho
Dong-A ST said it has signed a joint research and technology transfer contract for a double fusion antibody immunotherapy developed by Kanaph Therapeutics.Under the agreement, Kanaph Therapeutics will receive an upfront fee of 5 billion won ($3.8 million). Dong-A ST will also provide up to 18 billio
A local analyst said Hanmi Pharmaceutical's stock price will increase due to the earnings growth of Beijing Hanmi Pharmaceutical, backed by increased demand for cold medicine in China."Since China has been slowly changing into a With-Covid policy since December, the re-proliferation of Covid-19 is c
Handok and Novartis Korea signed a 2023 sales contract for three additional types of the latter's respiratory treatments in Korea.Handok was in charge of domestic sales of Onbrez in 2013, and with this contract, it will be in charge of distribution, sales, and promotion for three additional products
Pfizer Korea said it would focus on innovation by establishing a new Covid-19 unit, dedicated to strengthening Covid-19 vaccines and treatments businesses and speeding up the introduction of new drugs, within the company."We will unify the pandemic response by dedicating the dualized Corona 19 vacci